Align Technology, Inc. (0HCK.L)
USD 172.6
(-2.46%)
USD 172.6
(-2.46%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.07 Billion USD | 4.04% |
| 2022 | 1.99 Billion USD | 0.96% |
| 2021 | 1.97 Billion USD | 42.38% |
| 2020 | 1.38 Billion USD | 11.82% |
| 2019 | 1.24 Billion USD | 24.64% |
| 2018 | 996.36 Million USD | 29.31% |
| 2017 | 770.53 Million USD | 34.88% |
| 2016 | 571.26 Million USD | 25.42% |
| 2015 | 455.47 Million USD | 18.35% |
| 2014 | 384.86 Million USD | -4.71% |
| 2013 | 403.89 Million USD | 21.84% |
| 2012 | 331.49 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 523.11 Million USD | -9.12% |
| 2024 Q1 | 549.13 Million USD | 12.39% |
| 2024 Q2 | 575.58 Million USD | 4.82% |
| 2023 Q4 | 488.58 Million USD | -2.6% |
| 2023 FY | 2.06 Billion USD | 3.62% |
| 2023 Q1 | 531.66 Million USD | 6.62% |
| 2023 Q2 | 546.56 Million USD | 2.8% |
| 2023 Q3 | 501.63 Million USD | -8.22% |
| 2022 Q4 | 498.65 Million USD | 4.06% |
| 2022 Q3 | 479.21 Million USD | -4.82% |
| 2022 FY | 1.99 Billion USD | 0.96% |
| 2022 Q1 | 514.79 Million USD | -1.52% |
| 2022 Q2 | 503.48 Million USD | -2.2% |
| 2021 Q3 | 498.46 Million USD | 0.84% |
| 2021 Q4 | 522.73 Million USD | 4.87% |
| 2021 Q1 | 417.11 Million USD | 5.26% |
| 2021 Q2 | 494.29 Million USD | 18.5% |
| 2021 FY | 1.97 Billion USD | 42.38% |
| 2020 Q1 | 342.98 Million USD | 7.5% |
| 2020 Q3 | 349.87 Million USD | 17.29% |
| 2020 FY | 1.38 Billion USD | 11.82% |
| 2020 Q4 | 396.25 Million USD | 13.26% |
| 2020 Q2 | 298.29 Million USD | -13.03% |
| 2019 FY | 1.24 Billion USD | 24.64% |
| 2019 Q4 | 319.06 Million USD | 2.06% |
| 2019 Q3 | 312.61 Million USD | 27.34% |
| 2019 Q1 | 324.08 Million USD | 22.1% |
| 2019 Q2 | 245.49 Million USD | -24.25% |
| 2018 Q2 | 253.69 Million USD | 9.91% |
| 2018 Q1 | 230.81 Million USD | 11.78% |
| 2018 FY | 996.36 Million USD | 29.31% |
| 2018 Q4 | 265.43 Million USD | 6.8% |
| 2018 Q3 | 248.54 Million USD | -2.03% |
| 2017 Q4 | 206.48 Million USD | 6.76% |
| 2017 Q1 | 174.62 Million USD | 8.4% |
| 2017 FY | 770.53 Million USD | 34.88% |
| 2017 Q2 | 187.79 Million USD | 7.54% |
| 2017 Q3 | 193.41 Million USD | 2.99% |
| 2016 Q2 | 140.08 Million USD | 10.05% |
| 2016 Q1 | 127.29 Million USD | 8.36% |
| 2016 Q3 | 147.6 Million USD | 5.37% |
| 2016 FY | 571.26 Million USD | 25.42% |
| 2016 Q4 | 161.08 Million USD | 9.14% |
| 2015 Q2 | 116.3 Million USD | 13.84% |
| 2015 Q4 | 117.47 Million USD | -1.72% |
| 2015 FY | 455.47 Million USD | 18.35% |
| 2015 Q3 | 119.53 Million USD | 2.77% |
| 2015 Q1 | 102.16 Million USD | -0.78% |
| 2014 FY | 384.86 Million USD | -4.71% |
| 2014 Q2 | 96.74 Million USD | 1.36% |
| 2014 Q1 | 95.44 Million USD | 14.23% |
| 2014 Q4 | 102.96 Million USD | 10.12% |
| 2014 Q3 | 93.5 Million USD | -3.35% |
| 2013 Q2 | 85.78 Million USD | -43.16% |
| 2013 FY | 403.89 Million USD | 21.84% |
| 2013 Q1 | 150.92 Million USD | 64.94% |
| 2013 Q3 | 83.62 Million USD | -2.52% |
| 2013 Q4 | 83.55 Million USD | -0.09% |
| 2012 Q4 | 91.5 Million USD | 0.0% |
| 2012 FY | 331.49 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -461.545% |
| Accuray Incorporated | 142.61 Million USD | -1356.225% |
| Elevance Health Inc. | 36.23 Billion USD | 94.269% |
| AxoGen, Inc. | 149.33 Million USD | -1290.706% |
| Boston Scientific Corporation | 7.5 Billion USD | 72.331% |
| CVS Health Corporation | 40.68 Billion USD | 94.896% |
| Cardinal Health, Inc. | 5 Billion USD | 58.464% |
| Centene Corporation | 138.33 Billion USD | 98.499% |
| DaVita Inc. | 1.47 Billion USD | -40.899% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 95.429% |
| Hologic, Inc. | 1.26 Billion USD | -63.839% |
| Humana Inc. | 102.36 Billion USD | 97.971% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -90.039% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | -2.742% |
| Masimo Corporation | 867 Million USD | -139.542% |
| McKesson Corporation | 8.67 Billion USD | 76.06% |
| Patterson Companies, Inc. | 1.12 Billion USD | -84.227% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | -28.995% |
| ResMed Inc. | 1.36 Billion USD | -51.773% |
| Henry Schein, Inc. | 2.93 Billion USD | 29.288% |
| Teladoc Health, Inc. | 2.09 Billion USD | 0.675% |
| Universal Health Services, Inc. | 9.2 Billion USD | 77.446% |
| Veeva Systems Inc. | 1.25 Billion USD | -65.214% |
| Baxter International Inc. | 5.27 Billion USD | 60.607% |
| Becton, Dickinson and Company | 6.71 Billion USD | 69.058% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 29.901% |
| Danaher Corporation | 8.75 Billion USD | 76.278% |
| Stryker Corporation | 9.2 Billion USD | 77.448% |
| Medtronic plc | 16.12 Billion USD | 87.124% |